NCT00414167View on ClinicalTrials.gov

Craving, Binge Eating and Obesity

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Binge Eating DisorderObesity
Interventions
DRUG

bupropion

300 mg per day for 8 weeks

OTHER

Placebo

Placebo

Trial Locations (1)

06520

Yale University School of Medicine, New Haven

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Yale University

OTHER

NCT00414167 - Craving, Binge Eating and Obesity | Biotech Hunter | Biotech Hunter